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Abstract 
  Disabling motor signs of Parkinson’s Disease including akinesia, bradykinesia, 
tremor, and muscle rigidity are typically quantified by clinicians using the Unified 
Parkinson’s Disease Rating Scale (UPDRS). These subjective assessments, while useful, 
often vary among clinicians, making it challenging to evaluate medication and deep brain 
stimulation (DBS) therapies in multi-center trials. In this study, two designs for a multi-
joint rigidity-testing device were developed to enable objective, quantitative measures of 
rigidity. The investigator passively manipulated the subject’s joints while stabilizing the 
appendage distal to the joint with two opposing force transducers, providing a 
measurement of differential force during the movement. These forces were synchronized 
to the joint angle, measured by a motion capture camera system. Here, we show 
feasibility data for detecting changes in muscle rigidity in a parkinsonian non-human 
primate treated with Sinemet, Globus Pallidus internal (GPi) DBS and/or subthalamic 
nucleus (STN) DBS. 
  For design 1, the device was tested on six joints: elbow, wrist, shoulder, hip, knee 
and ankle, and in three states: MPTP, DBS stimulation, and drug therapy. Device 1 was 
effectively able to quantify rigidity and determine changes in rigidity states among all 
joints except elbow (p<0.05). For design 2, the device was tested on only the shoulder 
abduction/adduction and was tested in three states: MPTP, DBS stimulation, and post-
DBS stimulation. Design 2 was effectively able to quantify changes in rigidity as well 
(p<0.05). Ergonomics and durability were considered in the evaluation of the devices. 
While each device showed promising results, future iterations will also need to address 
several limitations of the current devices. The eventual goal of this rigidity testing device 
would be to use it in the clinic to assist neurologists in titrating medication levels and 
DBS parameters. 
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Introduction 
 Parkinson’s Disease (PD), as with many other neurodegenerative brain disorders, 
is becoming more prevalent as the population ages. An estimated five million people 
worldwide live with PD and the prevalence is expected to increase exponentially in the 
coming years (Xia et. al. 2012).  The current prevalence is approximately 0.3% for the 
overall populations of industrialized countries and 1% for the populations over 60 years 
old (de Lau et. al. 2004).  When a patient is diagnosed with PD, this indicates the 
degeneration of the dopaminergic neurons in the brain, depleting especially in the 
substantia nigra pars compacta (SNc), which is the main source of dopamine in the brain 
(Galvan and Wichmann 2008). The SNc is part of the basal ganglia (BG) which also 
includes the striatum, nucleus accumbens, Globus Pallidus (GP), and Subthalamic 
Nucleus (STN). When the SNc no longer transmits DA to the other BG nuclei, neural 
pathways begin to disassemble and degeneration to these nuclei begins. This 
degeneration causes the neural circuits to fall out of balance which affects downstream 
structures, such as the motor cortex (Mazzoni 2012). 
 Currently, there is no cure for PD, but there are several therapies available to 
patients when symptoms impair normal motor control. Dopamine replacement therapy 
using Levodopa (L-dopa; 3,4-dihydroxyphenyl-L-alanine), or another dopamine agonist, 
is the initial therapy used with PD patients (Xia et. al. 2012). While L-dopa remains the 
gold standard, drug-induced motor symptoms, such as dyskinesia, decrease the quality of 
life for PD patients (Schrag et. al. 2000). Additionally, L-dopa does not prevent the 
degeneration from the disease (Xia et. al. 2012). For some patients, the progression of the 
disease has caused them to become resistant to the drug therapy, or drug-intractable. It is 
hypothesized that the loss of dopaminoreceptive neurons in diseased patients causes L-
dopa resistance (Chiba et. al. 2012). For drug-intractable patients, more options are 
available but there are increased risks and costs. Deep brain stimulation (DBS) and 
neuroprotective drug therapies are currently being investigated (Johnson et. al. 2008, Xia 
et. al. 2012). 
 PD is a neurodegenerative brain disorder that results in a broad range of disabling 
motor signs, including akinesia, bradykinesia, tremor, and muscle rigidity (Mazzoni 
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2012). Rigidity, one of the cardinal symptoms of PD, can be equated to the amount of 
resistance to passively move a limb (Mazzoni 2012), independent of velocity and 
direction (Delwaide 2001). This is a common symptom that makes a patient stiff and can 
be easily evaluated during a patient’s visit to the physician. It is proposed that the 
increase in muscle stiffness observed through passive manipulation (Fung et al. 2000, 
Rätsep and Asser 2011) is due to the increase in the long-latency stretch reflex (Berardelli 
et al. 1983, Meara and Cody 1993) of the muscle (Xia et. al. 2012).  
 To determine the progression of a patient’s PD, a physician will use the Unified 
Parkinson’s Disease Rating Scale (UPDRS, section III) which quantifies the severity of 
motor signs from 0 (normal) to 4 (severe). These subjective assessments, while useful, 
often vary among clinicians (Imbert et. al. 2000, Patrick et. al. 2001), making it 
challenging to evaluate medication and deep brain stimulation (DBS) therapies in multi-
center trials (Van Dillon et. al. 1988). While using this scale is relatively accurate, there 
are disparities between physicians and between visits. Having a way to quantify these 
movements and rigidity would be ideal to give proper help to patients. 
 One way to determine the success of a therapy is to quantify the changes in a 
patient’s symptoms in response to the therapy.  Due to the controllable, passive method 
of assessing rigidity, quantifying rigidity has become a common method for determining 
therapeutic improvement. Additionally, parkinsonian rigidity has shown to track the 
progression of the disease in comparison to the other cardinal symptoms (Louis et. al. 
1999). Futhermore, rigidity seems to react well with drug treatment (Vu et. al. 2012) 
which is important for evaluating pharmaceutical therapies. Several previous studies have 
developed biomechanical devices to measure muscle rigidity at different joints in both 
human and non-human primates (NHPs) (See Table 1). Many attempts have used 
motorized actuators that can be selectively programmed to articulate joints across a range 
of angles and frequencies. However, correlating the results from these studies with 
clinical assessments of rigidity prove inconsistent (Prochazka et. al. 1997). While these 
devices have shown the feasibility to measure force changes at a specific joint, most 
devices are not usable with other joints, limiting their clinical use. In most cases, not all 
joints receive the same amount of improvement from a therapy; therefore, a single joint 
approach could be flawed. Emerging therapy testing is conducted in NHPs as the 
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parkinsonian NHP model has shown to be very effective at portraying PD motor 
symptoms (Fox 2010). Therefore, developing a device for NHPs to quantify the benefits 
of novel therapeutic techniques is in high demand.  
 
Table 1: Previous Research Quantifying Rigidity in PD 
Reference Rigidity sensor(s) Angle/Position tracking Joint 
of 
interest 
Webster, 1959* load cell Turntable (fixed movements) Elbow 
Kondraske, 1984* strain gauge potentiometer Elbow, 
Knee 
Lakie, 1984* suction EMG electrodes potentiometer Wrist 
Watts, 1986* strain gauge magnetoresistive potentiometer Elbow 
Chan, 1987* force transducer potentiometer Knee 
Brown, 1988 angular velocity profile goniometer Knee 
Caligiuri, 1989* resistive strain gauges potentiometer Finger 
Caligiuri, 1992* force transducer rotation transducer Finger 
Caligiuri, 1994 resistive strain gauges linear potentiometer Wrist 
Relja, 1996 torque sensor potentiometer Elbow 
Prochazka, 1997 two air-filled force pads length gauge Elbow 
Fung, 2000* torque motor output potentiometer Wrist 
Patrick, 2001 air-filled differential force 
transducer 
Piezoelectric gyroscope Wrist, 
Elbow 
Xia, 2004* surface EMG electrodes motor axis rotation Wrist 
Shapiro, 2007* torque transducer capacitative transducer Elbow 
Hong, 2007 Rigidity analyzer® solid-state gyroscope Elbow 
Mak, 2007* dynamometer motor axis rotation Trunk 
Sepehri, 2007 strain gauge transducer potentiometer Elbow 
Endo, 2009 three-axis force sensors gyroscope Elbow 
Levin, 2009 Ag-Cl surface EMG 
electrodes 
goniometer Elbow 
Mera, 2009*^ three-axis force transducer motor axis rotation Elbow 
Cano-de-la-Cuerda, 
2011 
dynamometer motor axis rotation Trunk 
Niazmond, 2011 sheet force sensor 3-axis acceleration sensors Elbow 
Park, 2011 load cell potentiometer Wrist 
Little, 2012 strain gauge goniometer Wrist 
Dai, 2013 force sensitive resistors 3-axis gyroscope Elbow 
* - indicates device is actuated  ^ - indicates primate study    
Rigidity analyzer® is developed by Neurokinetics (Edmonton, AB). 
 In this study, we developed a multi-joint rigidity-testing device to enable 
objective, quantitative measures of rigidity with millisecond resolution. The investigator 
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passively manipulated the subject’s joints while stabilizing the appendage distal to the 
joint with two opposing force transducers, providing a measurement of differential force 
during the movement. These forces were synchronized to the joint angle, measured by a 
motion capture camera system. Here, we show the development, calibration, and 
validation of a multi-joint device for detecting changes in muscle rigidity in parkinsonian 
NHPs treated with Sinemet, GPi-DBS and/or STN-DBS. 
 
Materials and Methods 
Non-human primate subjects 
 This study involved rigidity testing, performed on two rhesus monkeys (Macacca 
mulatta) that were previously rendered parkinsonian. Subject P (19 y.o., ♀, 10.0 kg) was 
systemically induced parkinsonian with 3 daily injections of 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP, Toronto Research Chemicals Inc., Brisbane, Ontario, 0.4-0.6 
mg/kg) causing severe parkinsonian symptoms, and had two DBS leads implanted in the 
STN and GPi. In contrast, Subject F (18 y.o., ♀, 10.2 kg) was given several inter-carotid 
injections of MPTP which produced mild symptoms and had one DBS lead implanted in 
the STN. These subjects tested out two different device designs.  All procedures were 
approved by the Institutional Animal Care and Use Committee of the University of 
Minnesota and complied with United States Public Health Service policy on the humane 
care and use of laboratory animals. 
 
Force Sensor and DAQ Selection 
 Based on previous research shown in Table 1, there are several force sensors that 
could be used, such as load cells, strain gauges, force sensitive resistors (FSRs), and 
many other torque sensors. An extensive search was conducted on possible candidates for 
the device in this study (Table 2).  
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Table 2 – Force sensor comparison 
Name Company Type Height Force Range 
Cost per 
sensor 
Flexiforce Tekscan 
Force Sensitive 
Resistor 
1 mm 
circuit 
dependent 
$25 
FC2231 
Measurement 
Specialties 
Load  Cell 25 mm 0 to 100 lbf $45 
KDN 
1865 
Honeywell Force transducer 7.62 mm 0 to 50 lbf $102 
FS03 Honeywell Force transducer 16 mm 0 to 3 lbf $115 
Mini-45 ATI Force transducer 15.7 mm 0 to 120 lbf $3,900* 
Nano-25 ATI Force transducer 21.6 mm 0 to 100 lbf $4,250* 
*Need to purchase interface board and cable which is an additional $1,885. 
 
 To determine the feasibility of using sensors that would not restrict the sensing on 
the limbs, hand measurements were taken to test the ergonomics of using a sensor with 
different heights. The set-up and results of this testing are shown in Appendix 1. Based 
on this analysis, all of the sensors above were determined to be feasible in terms of hand 
ergonomics, but the smaller the sensor height the better. The three sensors that were 
heavily considered were the Flexiforce FSRs, Measurement Specialties FC2231 load 
cells and ATI Nano-25 sensors. One of the main motivations for this project was to create 
a device that could be replicated by other labs and used to capture rigidity. The main 
goals for this study were to create a rigidity measuring device that is efficient, easy-to-
use, and cost efficient. Therefore, FSRs were investigated first to see if they could be 
used to capture rigidity. Unfortunately, they were unable to be used due to the fact that 
the baseline for the sensors changed when the sensors were moved, meaning that the 
calculations for force changes could not be calculated (data not shown).  The next sensor 
investigated was the FC 2231 load cell from Measurement specialties. After initial testing 
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of the sensors, it was determined that the FC 2231 sensors had the sensitivity to be used 
in our device.  
 For the data acquisition (DAQ) board selection, the two main DAQ systems 
considered were National Instruments DAQ (NI-DAQ) and Arduino. Since both the NI-
DAQ and Arduino can be paired with Matlab, and additionally an Arduino is much more 
affordable, Arduino was initially chosen for testing of Device 1. The reason for pairing 
the data acquisition with Matlab is to streamline offline analysis, as well as develop a 
graphic user interface (GUI) in Matlab to provide feedback for the experimenter as a 
future direction.  
Design of Device 1 
 The rigidity measuring device (Device 1) was composed of two FC 2231 load 
cells (Measurement Specialties, Hampton, VA) attached to the researcher’s thumb and 
index/middle finger with Velcro straps (Velcro, Manchester, NH) (Figure 1B). Two metal 
stabilization plates were secured to opposite sides of the primate’s limb with an 
adjustable Velcro strap. Indentations in the plates provided a stable point for pressure 
application of the load cells and minimized forces and torques in unwanted directions 
(Figure 1A).  The Velcro attachments allow the rigidity-testing device to fit any size limb 
in order to test a variety of joints. The data from the sensors was transmitted to an 
Arduino Uno microcontroller (Ivrea, Italy). Position data was collected using an infrared 
motion capture system (Vicon, Centennial, CO) as shown in Figure 2A. Reflective 
markers were placed at strategic locations on the body of the non-human primate as well 
as on the researcher’s hand. An analog synchronization output from the Vicon system 
was sent to the Arduino microcontroller to co-register the force and position data offline 
(Figure 2C). 
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Figure 2: Device 1 schematic.  A) Position of the shoulder, elbow, and wrist during elbow joint 
articulation.  B) Elbow angle during articulations.  C) Schematic drawing of data acquisition set-up for 
Device 1. D) Differential force measurements during elbow articulations.  E) Force - angle curves of elbow 
flexion/extension. 
Figure 1:  Device 1 sensor-transducer interface. A) For each transducer, a metal pad was sewn onto 
a brown fabric loop that slides along the Velcro to create a stable surface for each finger digit while 
minimizing torque on the transducer. With the transducers attached to the fabric loop, the set-up can be 
adjusted to different locations on the body to capture rigidity across multiple joints.  B) Load cells were 
attached to digits 1 and 2/3 with Velcro.  C) Shows the overall set-up for Device 1. 
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 While measuring rigidity is the same concept between humans and NHPs, through 
passive manipulation of the joints, cooperation to wear rigidity devices poses a limitation 
to most of the devices listed in Table 1. Therefore, one of the design elements of Device 
1 was the experimenter’s ability to release the limb of the animal if the animal was not 
allowing for passive manipulation. The device was designed so that the experimenter 
could easily detach the sensors and remove their hand from the animal. The Velcro strap 
used can adjust to the animal’s limb, whether they were testing on the arm, leg, etc. 
Design of Device 2 
 The second design for the 
rigidity measuring device is very 
similar to Device 1, since it is 
composed of two FC 2231 load cells 
(Measurement Specialities, 
Hampton, VA) but the sensors are 
connected with Velcro (Velcro, 
Manchester, NH) onto the limb of 
the animal and a 3D printed 
(acrylonitrile butadiene styrene) cap 
has been to fit onto the sensing tip of 
each sensor. This provides a surface 
for the thumb and fingers of the experimenter to rest and the height of the caps were 
designed so as to not touch the non-sensing areas of the sensors. This cap design should 
allow any pressure applied to the cap to be transferred to the sensor tip.  Again, the 
Velcro attachments allow the rigidity-testing device to fit any size limb in order to test a 
variety of joints. For this second device the NI-DAQ (NI USB-6216 ) was used to acquire 
the data, since the infrared camera system was Motion Analysis (Santa Rosa, California) 
and the NI-DAQ feeds directly into the software interface of the Motion Analysis 
program. Unlike device 1, the force data is synced directly with the angle data in the 
Motion Analysis, so there is no need for a sync pulse and co-registration calculation. 
Figure 3: Device 2 schematic. Schematic drawing of data 
acquisition set-up for Device 2. 
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Reflective markers were placed at strategic locations on the body of the NHP as well as 
on the researcher’s hand. 
 
 
 
 
 
 
 
 
 
 
 
Calibration 
Load Cell Calibration 
A calibration device was built to translate voltage output from the load cells to actual 
force applied (see Figure 4). The sensors were each calibrated separately with known 
weights that were stacked onto the calibration device (Figure 4B). A small rectangular 
wooden box with open ends was built to stabilize the weighted end on the device. Zinc 
discs were tapped together into six bundles with five discs per bundle. Each bundle was 
labeled and measured on a digital scale prior to calibration testing. The Arduino and the 
NI-DAQ had different input currents so both microcontroller set-ups were calibrated.  
 
 
 
Figure 4: Device 2 cap–sensor interface. A) Two 3D printed caps used for Device 2.  B) Device 2 set-up 
with the sensors velcroed to the forearm to manipulate the shoulder abduction/adduction, fingers rest on the 
caps of the device for rigidity measurement. 
A B 
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Load Cell Sensitivity testing 
 After sensors were calibrated, the load cell 
sensitivity was investigated. To test how sensitive 
the load cells were to changes in resistance, a 
wooden ‘arm’ was built to be able to simulate 
movements with the differential sensor set-up. In 
addition, hooks were screwed in to be able to place 
rubber bands on the arm and add resistance. 
Unfortunately the data was inconclusive due to 
non-linearities in the rubber bands for the 
consistency in testing (data not shown). 
 
Load Cell Performance  
Before conducting a study with parkinsonian 
NHPs, the sensors were tested on a human elbow to 
ensure the sensor differential set-up would capture changes in rigidity. To test the 
performance of the sensors, the sensors were tapped onto a healthy human forearm. The 
subject was asked to relax his elbow and allow passive manipulation. After several trials 
of passive movement, the subject was asked to resist movements to his elbow. The two 
Figure 6: Wooden Arm Calibration. 
Wooden arm has a rubber band hooked, 
acting as the bicep. Additionally three 
markers helped to calculate angle of the 
wooden elbow joint.  
Figure 5: Calibration 
device. A) The 
calibration device has a 
weight-application rod 
that is hidden by the 
rectangular box (red 
arrow) which 
concentrates the weight 
onto of the load cell. 
The bag (green arrow) 
holds the counter-
weight for the weight-
application rod. B) The 
zinc discs are visible 
within the rectangular 
box. 
A B 
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states can be compared to see if the overall concept for the device will be able to perform 
accurately. 
Experimental Recordings 
 For the NHP experiments, both subjects were seated and awake. The NHPs were 
trained to allow passive joint manipulations months leading up to the device testing. For 
each trial, the animal was manipulated approximately 30 cycles (e.g. extension/flexion, 
abduction/adduction). Additionally, the experimenters were trained on how to properly 
use the rigidity measuring device prior to the experiments. With the relatively simple set-
up of the device for experimenter convenience, the device-use training was a brief 
meeting prior to recording. 
Subject P experiment 
 The stimulation settings for each animal were slightly different depending on the 
other protocols that were being investigated. The experimental procedure for Subject P 
helped to compare the effectiveness of therapies for PD as rigidity was tested under three 
experimental conditions: 1) MPTP, 2) MPTP+DBS, and 3) MPTP+Sinemet. The two 
DBS settings tested were the STN-DBS stimulation using 3 radial contacts each at 400 
µA and at 130 Hz and GPi-DBS stimulation using 3 radial contacts each at 300 µA and at 
130 Hz. For rigidity measuring during DBS therapy, stimulation was turned on for at 
least five minutes prior to performing passive manipulations.  
 After stimulation was terminated and given a >60 minute washout period, 
Sinemet therapy was given through oral administration of 200 mg (150 mg levodopa, 50 
mg carbidopa, Merck, Whitehouse Station, NJ). Passive manipulations were performed at 
least 60 minutes after drug administration to allow for drug absorption. Passive 
manipulations were conducted through the flexion and extension of several joints 
including the wrist, elbow, shoulder (abduction/adduction), hip (abduction/adduction), 
knee, and ankle contralateral to the STN and GPi DBS implants. 
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Subject F experiment 
 Subject F was part of a 15-day study to investigate coordinated reset therapy with 
STN-DBS, with the last two days devoted to investigating clinical STN-DBS therapy. 
There was no L-Dopa given to the animal during the study and two types of STN-DBS 
stimulation approaches were tested in the context of rigidity measurements. The two 
types of STN-DBS used were “coordinated reset” STN-DBS and high-frequency clinical 
STN-DBS. For coordinated reset, the DBS contacts are randomly stimulated in different 
bipolar configurations. For the clinical STN-DBS, contacts 1 and 2 were used to 
stimulate at an amplitude of 1V with 120 µs pulse width at 130 Hz. Passive 
manipulations were conducted through the abduction and adduction of the shoulder 
contralateral to the STN-DBS implant at multiple time points during the session: 
baseline, 30 min during stimulation, 90 min during stimulation, 30 min post-stimulation, 
and 60 min post-stimulation. The schedule for the 15-day study was as follows: Days 1-5 
were assigned as uncoordinated reset DBS trials, Days 6-13 were assigned to no 
stimulation and Days 14 and 15 were assigned to clinical DBS. For the days with no 
stimulation, baseline data was still collected at the same time intervals as the days with 
stimulation, to keep the protocol consistent. The rigidity measuring device testing with 
Subject F was used to observe device consistency within days and measuring relative 
changes across days to show the chronic effects post coordinated reset STN stimulation 
and the acute effect post clinical STN stimulation. Due to damage to the device early in 
the testing, only days 14 and 15 were usable for analyzing. 
Data Analysis 
All analysis was performed offline in Matlab (v2012b, Natick MA). See Appendix 2 for 
the analysis code.  The differential force signal from the load cells and the position 
signals were low-pass filtered (fifth order butterworth, cutoff 12.5 Hz). For each trial, the 
first and last ten seconds of movements were removed to allow for analysis of 
movements that are consistent and when the animal is most relaxed. The angle was then 
calculated using the law of cosines.  
Equation 1:                      
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Since the position of the three markers is measured with the infrared camera systems, the 
equation can be re-arranged to solve for theta: 
Equation 2:            
        
   
 
 Using the angle data, extension and flexion segments were calculated by detecting 
the direction of angle changes. Each juxtaposed flexion and extension was combined 
serially as one movement. Principal component analysis was conducted on the angle data, 
using a cluster algorithm in Matlab, to reject outlier movements that may have resulted 
from voluntary movement during the recording session. The cluster analysis was 
performed with nominally five group designations; however, this number was adapted 
manually according to the number of visually unique outliers. The unit on the sensor data 
output as voltage into Matlab (for Subject P) or Motion Analysis (for Subject F) was 
converted to force (newton) using the calibration curves (see Figure 7). The areas for 
each movement were defined by first plotting the extension and flexion manipulations on 
a Force vs. Angle plot, and then calculating the area between the flexion and extension 
curves and subtracting the two areas to find the area between the two curves.  
For statistical comparisons, non-parametric tests were conducted due to the small 
sample size of each trial and the lack of normally distributed data. More specifically the 
Kruskal-Wallace test with a significance level of p<0.05 was performed to show 
significance among different trials since each trial could have variable sample sizes. 
Additionally, the desire to compare more than two groups requires the Kruskal-Wallace 
test, since the test is a one way analysis of variance. The Dunn test for multiple 
comparisons was conducted post-hoc for each data set that rejected the null hypothesis 
for the Kruskal-Wallace test. If the null hypothesis for the Dunn test was rejected, this 
was indicated by significance bars in each of the graphs (p<0.05). 
Results  
Arduino and NI-DAQ calibration 
 As mentioned in the methods, a calibration device was built to translate voltage 
output from the load cells to actual force applied (Figure 5). Since the Arduino and the 
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NI-DAQ had different input currents, load cells were calibrated in both DAQ set-up was 
recorded separately (Figure 7). With R
2
 > 0.99 for all calibration curves, there was high 
confidence going forward that the load cell voltage would correctly converted into the 
unit of newton. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Calibration Curves. Calibration fits for sensor01 (blue) and sensor02 (red) for both A) Arduino 
and B) Motion Analysis set-ups. 
Figure 8: Arduino Lag Calculation. Load cell output voltage (blue) and infrared camera position data 
(red) with A) lagged voltage data and B) resampled load cell voltage data. 
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Lag component in Arduino DAQ 
When analyzing the data from Subject P the voltage data from the load cells did not align 
well between the position data from the infrared camera system. In the Arduino set-up, 
there was a pulse sent from the camera system to the Arduino (see Figure 2C methods) to 
sync the load cell and position data. Even with the sync pulse, the position data seemed to 
lag consistently behind the voltage data (Figure 8A). To correct for this delay, the load 
cell data was resampled with a frequency of 1.0425 Hz (Figure 8B). 
Sensor Performance 
Before testing with the NHPs, the load cells were tested on a healthy human elbow to 
ensure the sensor differential set-up would capture changes in rigidity. The load cells 
were tapped onto a healthy human forearm, with the sensing tip pointing out from the 
limb, as not to cause discomfort. The two states captured were passive manipulation of 
the elbow (Figure 9A), and actively resisting elbow joint articulation (Figure 9B), used as 
an approximate surrogate of rigidity. Average area and standard deviation of the force-
angle curves were calculated and compared (Figure 9C,D). There was 145% difference in 
normalized area (defined by the area between extension and flexion force-angle curves, 
divided by the number of degrees used in the joint articulation) calculated between the 
resistive state and the passive state. Through one-way Kruskal-Wallace test, the null 
hypothesis was rejected meaning the two states were from different sample populations 
(p= 0.0223). 
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Device 1 - Validation testing  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: Sensor Performance – Resistive vs. Passive.  Extension (green) and flexion (blue) force-angle 
curves, with the average curve (black) for A) passive state and B)resistive state. C) Shows the passive (red) 
and resistive (black) state trials plotted on the same axes D) Normalized area for passive state (red) and 
resistive state (black) with standard deviation bars being displayed. 
Figure 10: Device 1 Validation. Force-angle curves for MPTP (grey) and DRUG (cyan) knee joint trials, 
with the average force-angle for each plotted in bold (black for MPTP, blue for DRUG) for A) Day 1 and 
B) Day 2. C) Normalized areas from the average force-angle curve (black) compared with the UPDRS 
Score (green) that the experimenter qualitatively determines. 
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 During the two-day testing of device 1, Subject P was tested in both the rigid 
MPTP state and drug treated state (Sinemet, 150 mg). The force-angle plots for the 
MPTP and drug trials for both day 1 (Figure 10A) and day 2 (Figure 10B) reflect the 
consistent curves within a day but less consistent curves between days.  This partly 
stemmed from slightly different angles in which the experimenter used to articulate the 
joint, which in the case of Figure 4 was the knee.  Thus, the area between the extention 
and flexion force-angle curves was normalized by the angle range (Figure 10C). By 
normalizing by the angle range, movements at different angle ranges could be compared. 
There was a 0.78% difference between the normalized area for the drug trials between 
days 1 and 2. Furthermore, there was a 70% decrease in normalized area between the 
MPTP and drug state from day 1, while there is only a 20% decrease for day 2. A one-
way Kruskal-Wallace test was conducted on all four trials and, the null hypothesis was 
rejected meaning there are at least two different sample populations (p = 2.2883e-18) 
which could be interpreted as two different states. 
 Also plotted in Figure 10C are the UPDRS scores that the researcher assessed on 
Subject P prior to running the test with the device. Since the UPDRS scores are the 
standard for measuring rigidity, they will be used as a validation measure that the device 
was working properly and capturing appropriate level of rigidity. From Figure 10C, it 
seems that the relative changes in normalized area do not match the UPDRS scores 
directly, but rather follow similar trends. For example, the UPDRS scores decrease from 
the MPTP trials to the drug trials and the same can be seen in the normalized areas for 
both days. 
 Device 1 was captured data from six joints, including: the elbow, wrist, shoulder, 
hip, knee, and ankle from a parkinsonian non-human primate (Figure 11). As shown in 
Figure 11, the device was tested in three conditions, including MPTP, GPi-DBS, and 
Sinemet. The joint that showed the most consistency, based on average standard 
deviation of the normalized area across all three trials was the knee (± 0.0313) and the 
joint with the least consistency was the ankle (± 0.2943) with the wrist also showing a 
lack of characteristic force-angle curves. The slope of the flexion or extension was 
considered and analyzed, but the slopes did not correlate well with changes in rigidity 
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(data not shown). The plots shown in Figure 11 have the same axes as other trials on the 
same joint; therefore, the force data for the MPTP trial for hip was collected at a much 
different angle range than the GPi-DBS trial. While a difference in angle range length can 
be compensated for with normalization, the actual angle range at which the rigidity data 
was collected cannot be changed 
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Figure 11: Device 1 multi-joint testing. Force-angle curves for MPTP, GPi-DBS, and drug trials across 
six different joints on Day 1. Extensions (green) and flexions (blue) were averaged (black) for each trial. 
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 Note that there was no UPDRS score taken before the GPi-DBS trials, so there is 
no UPDRS score to report. It should also be mentioned that the elbow MPTP trial was the 
first trial for the researcher, and there seemed to be a one trial learning curve for the 
researcher to become comfortable with the device, so there was no accurate MPTP data 
for the elbow. When comparing the UPDRS score to the normalized area for each trial, in 
general, the normalized area changes match well with the UPDRS scores.  A one-way 
Kruskal-Wallace test was conducted on each joint trials and, the null hypothesis was 
Figure 12: Device 1 multi-joint results. Comparing the normalized area (blue) and UPDRS scores (red) 
for MPTP, GPi-DBS, and drug states across all six joints.  
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rejected for all of the joints: wrist (p=6.4410e-05), shoulder (p=1.2786e-11), hip 
(p=2.6660e-07), knee (p=1.1394e-10), and ankle (p=8.4770e-04) except the elbow, 
meaning device 1 was able to detect more than one population, or in this case rigidity 
state, among each joint. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 From Figure 13C, there was a 95.1% decrease between the normalized area for 
the MPTP and GPi-DBS stimulation, while there was only a 70.4% decrease between the 
MPTP and drug trial for day 1. As for day 2, there was an 18.9% increase in normalized 
area between the MPTP and STN-DBS state and only a 21.5% decrease between the 
MPTP and drug trials. A one-way Kruskal-Wallace test was conducted on each day of 
trials and, the null hypothesis was rejected for each day (day1: p= 1.1394e-10; day 2: 
p=2.5112e-04), further supporting the detection of multiple rigidity states. 
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Figure 13: Device 1 comparing therapies. A) Force-angle curves for MPTP (black), GPi-DBS (red), and 
drug (blue) for the knee. B) Force-angle curves for MPTP (black), STN-DBS (red), and drug (blue). C) The 
normalized area calculated for MPTP (blue), drug (green) and either GPi-DBS (orange) and STN-DBS (red) 
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* 
* * 
* * 
21 
 
Device 2 – Validation Testing 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Subject F was tested in both the rigid MPTP state, during STN-DBS, and 30 
minutes after STN-DBS (Post-STIM) for abduction and adduction to the shoulder joint. 
The force-angle plots for Day 14 of testing with Subject F is shown in Figure 14A and 
average normalized area with standard deviation was compared to the qualitative UPDRS 
Score in Figure 8B.  In Figure 14A, there is a 4 degree gap between the Post-STIM trials 
and the MPTP trials. In Figure 8B, the area between the extention and flexion force-angle 
curves was normalized by the angle range. By normalizing by the angle range, 
movements at different angle ranges could be compared. There was a 69.7% decrease 
from the normalized area of the MPTP trials to the normalized area of the STN-DBS 
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Figure 14: Device 2 Validation. A) Force-angle curves for MPTP (grey), STN-DBS (pink) and 30 
minutes post-stimulation (cyan) shoulder joint trials, with the average force-angle for each plotted in 
bold (black for MPTP, red for STN-DBS, and blue for Post-STIM). B) Normalized areas from the 
average force-angle curve (black) compared with the UPDRS Score (green) that the experimenter 
qualitatively determines, standard deviation is plotted as error bars. 
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trials. Furthermore, there was a 2.12% difference between the normalized area of the 
MPTP and Post-STIM states. A one-way Kruskal-Wallace test was conducted on all three 
trials and, the null hypothesis was rejected meaning there are at least two different sample 
populations (p = 9.3043e-05) which was be interpreted as two different states. 
Discussion 
This study involved the design of a rigidity measuring device and testing in 
parkinsonian NHPs.  The system enabled quantitative measurement of joint resistance 
and has future potential for titrating PD therapies, including deep brain stimulation and 
dopamine replacement. In comparison to previous systems that measure muscle rigidity, 
the system described here provided a method to evaluate rigidity about multiple joints 
with a single device set-up that required minimal effort to transition amongst joints. 
Device Interpretations 
 The main result from the recordings was the measurement of the area from the 
force-angle curves for each joint. The indicator for a change in rigidity was a significant 
increase or decrease in the area between the flexion and extension curves on the force-
angle plots. These results have been found by several other papers (Caliguiri 1989, 
Caliguiri 1992, Dai 2013, Endo 2009, Fung 2000, Mera 2009). Other studies mention 
using the slope as a means to indicate a change in rigidity (Caliguiri 1994, Mera 2009). 
However, the measurements obtained in the parkinsonian non-human primates did not 
exhibit a consistent slope during extension and flexion phases of the movement. One 
possibility for this difference is that a rubber stopper placed at the base of the metal 
transducer hole in device 1 may have caused an elastic effect on the shape of the force-
angle curves. 
Device Ergonomics 
 When creating a device that interfaces directly with the user, ergonomics must be 
considered to allow for comfortable and efficient use of the device. The use of Velcro 
straps on both the experimenter’s hand and the subjects’ limbs proved to be effective at 
creating an adjustable and stable attachment method. For device 1, the adjustable loops 
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that were attached to the transducer allowed for efficient aligning of sensors before 
beginning a trial. While the ergonomics of the measuring device were a primary 
consideration in the design of the device, there were some limitations associated with 
each of the final designs.  One limitation to both device was the height of the sensors, and 
the bulkiness it created when the researcher tried to grasp and manipulate the limb while 
wearing the device. Additionally, device 2 had 3-D printed caps that were not completely 
form-fitting, which resulted in pressure on the cap that was not necessarily being 
distributed entirely as a force in the direction tangential to the load cell button and instead 
may have resulted in torques. The 3-D printed cap over the load cell button also limited 
the area for the fingers to grasp, while in device 1 the load cells were directly attached 
with Velcro to the digits of the experimenter.  
Device Durability 
 In addition to ergonomics, durability is another concern when building a device. 
Both device concepts had strengths and flaws in regard to durability. For device 1, the 
attachment of the load cells to the hand of the experimenter increased durability. The 
design allowed for the experimenter to pull the load cells away from the subject and 
avoid damage. A flaw in the device 1 design was in the attachment of the metal 
transducer interface. The transducer interface was sewn on to fabric loops. This posed a 
problem because after several trials under resistive forces, the stiches on the transducer 
began to loosen and ultimately fail. This failure was experienced when testing device 1 in 
Subject F. Device 2 had a more expensive durability issue. The caps that were placed on 
the sensing tip of the load cells had space between the cap and the sensing unit so the cap 
could be placed over the sensors. The problem with this space is that it caused the caps to 
become slightly unstable and teeter during the joint articulations. During the experimental 
sessions, the teetering to one side or the other on the load cell tip caused the tip to 
dislodge from the primary unit several times, ultimately failing due to unintended torques 
at the sensing tip. In addition, since device 2 was attached via velcro to the limb of the 
subject (not to the fingers of the experimenter), there was not enough time to pull the 
device away from the subject before damage to the sensor occurred. On the positive side, 
the 3D printed caps for device 2 were unaltered and maintained shape through torques. 
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Thus, the 3D printing materials and methods used to create the device 2 caps should be 
used in future 3D printing endeavors. 
Sources of Error 
 After completing the studies, there were several aspects of the study where more 
information would have been helpful and a more strict protocol would have supported a 
better result. One such change in the protocol would be the placement of sensors. One 
idea could be to keep the Velcro strap on the subject for the whole trial period for the day 
and see if that could improve the intra-day variance in trials. The way the testing was 
done in the study, the Velcro straps were taken on and off between the trials and moved 
around to the limb of interest. While the straps were returned close to the previous spot, 
there was most likely some error in placing and replacing the straps between days. 
 The device 1 and 2 both followed the UPDRS score fairly well but there were a 
few cases where differences existed. One source of error could stem from the fact that the 
UPDRS was not recorded simultaneously when the rigidity was measured by the device. 
This was mostly due to the fact that it was easier to record the UPDRS all at once and 
then record the rigidity via the device. The reason why this might be a concern is for the 
drug trials. With more time elapsed before testing the rigidity device, there was more 
time for the absorption of the drug. This could cause further reduction in rigidity relative 
to the UPDRS score taken minutes before. 
 Since the rigidity measurement experiments were not the main studies for each 
NHP, the testing of the rigidity measurement device was limited. Subjects that have been 
trained for passive manipulation, implanted with DBS leads and induced parkinsonian, 
were sparse therefore explaining why testing was limited. With only two short studies 
being conducted with the devices, it is conceivable that with more testing, more 
information about these devices could be collected.  
 Several studies have mentioned using a surface EMG to detect if the subject is 
resisting or allowing passive manipulations (Endo 2009, Fung 2000, Mera 2009). For the 
current study, we were unable to add the EMG sensors to the protocols for Subject P and 
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Subject F due to the already dense protocols (Subject P) or limitations due to the study 
(Subject F). Having EMG sensors would be very important for future testing so that 
active resisting of the subject could be detected and the trial ruled out of analysis. In this 
study, the experimenter noted if they felt the subject resisting passive manipulation, 
which was qualitative and could lead to contradicting results. 
 A limitation of the load cells from Measurement Specialties was the lack of 
sensing in the tangential plane of the limb. The load cells could only detect in one 
direction, which was the force normal to the limb. An additional issue with the device 
was the lack of feedback for the experimenter to know what angle range was from the 
previous trials. The absence of feedback led to the angle range for different trials to be 
very different. The biggest problem with not having the same angle range is the muscle 
recruitment to achieve that movement at that angle range. Therefore even if the area is 
normalized by dividing the force-angle area by the angle range, this doesn’t compensate 
for the fact that the different trials could be activating different muscles and measuring 
different joint rigidities. 
Future Directions 
 Neither device 1 nor devices 2 are a finished product, but move along the path to 
a final working device that could have broad application to preclinical and clinical 
studies. To address an ergonomic concern, the next generation should have shorter load 
cells. While the Measurement Specialties load cell had the sensitivity and functionality to 
capture rigidity, the size of the sensors would limit a study if the NHP limbs were large or 
if the experimenter had small hands. 
 Device 1 had durability issues with the transducer interface, while device 2 had 
sensor durability problems. The set-up for device 1 would be the preferred orientation of 
the sensors given on feedback from testing. Device 1 set-up allows the experimenter to 
remove the device quickly from the subject, which is ideal working with NHPs. 
Therefore, improving the transducer interface of Device 1 would be the next direction to 
further improve this device. If the interface of the transducer for device 1 is 3D printed 
with two plastic brackets on either side of the transducer interface, then Velcro could be 
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looped through the brackets, similar to a belt,  and the transducer would have a specific-
size 3D printed opening for the load cell tip to lock into the transducer interface. This 
would take the best aspects from both device 1 and device 2. Also for future studies, it 
would be ideal to make at least two sets of transducers since two different lengths of 
Velcro were used to adjust to the lower limbs vs the upper limbs / distal joints. 
 The next generation device should incorporate a way to track angle changes 
online, since the variability in angle ranges across trials was a major limitation to this 
study. The joints that had the most consistent area calculations were the joints that had 
the most consistent angle ranges across different days and therapeutic states. With the 
current set-up, the experimenter was expected to manipulate the limb of interest in the 
most accurate and consistent manner possible, as to capture a consistent angle. That tactic 
seemed to fair well within the same trial. But between trials, it would be very difficult for 
the experimenter to know the exact angle range that they tested an hour before. The 
rigidity changes in the joint from a therapy condition could further complicate the 
experimenter’s memory of the movement previously performed. To alleviate this 
problem, the experimenter would need feedback from the infrared camera system. This 
could be achieved by streaming the data from the infrared cameras into Matlab and 
displaying the angle calculation in a Matlab GUI. In addition, an audio feedback could be 
used. The experimenter could wear head phones that would emit a frequency based 
position method, where the frequency of the sound will change as the experimenter 
changes the angle of the limb, and the experimenter would listen to stay within a range of 
frequencies. 
Conclusion 
  The objective of this research was to build an accurate, inexpensive, and easy-to-
use rigidity measurement tool to quantifying parkinsonian rigidity. The results indicate 
that the rigidity-testing device presented here is sensitive enough to measure changes in 
rigidity resulting from dopamine replacement and DBS therapies. Furthermore, the 
unique handheld differential load cell design allows for testing of multiple joints (wrist, 
elbow, shoulder, ankle, knee, hip) and has potential to be extended further. 
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Currently, clinicians use UPDRS to measure rigidity in Parkinson’s disease 
patients, but the scale has a small range and is subjective to inter-clinician variability. 
Future iterations of this rigidity testing device could be used in the clinic to assist 
neurologists in titrating medication levels and DBS parameters. However, future 
iterations will also need to address several limitations of the current device, including the 
inability to quantify transverse torque at the point of contact of the sensor, confounding 
forces due to the subject actively resisting during manipulations, and possible variability 
in measurement due to inconsistent placement of the sensors on the subject’s limbs 
between trials.  
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Appendix 1: Hand Ergonomics 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3: Hand grip test results 
 
Set-up Avg. distance between 
calipers 
Notes 
no sensors 13.36cm - 
black foam sensors 9.27 cm 
Difficult not to torque 
the foam sensors with 
large interface 
grey foam sensors 8.58 cm 
Less stable than black 
foam sensors 
 
grey foam  sensors – diameter = 25 mm, height = 22 mm 
black foam sensors – diameter = 45 mm, height = 16 mm 
 
Conclusions: The height of sensors can be in the 22mm range, and the larger the 
diameter of the sensor the better, as it provides more stability for gripping. 
 
 
 
 
 
 
A 
Figure 15: Hand grip measurements. Hand gripping measurements for A) no sensors B) black foam sensors 
C) grey foam sensors. The measured distance was between the outside edges of the two calipers. 
B C 
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Appendix 2 – Matlab Code 
% -------------------------------------------------------- 
% 
% interpvicon.m 
% 
% Created by: Kevin Mohsenian 
% Updated: 07-27-2014 
% 
% Description: Code that creates force-angle variables 
%   over a specified time window of interest. 
% 
% -------------------------------------------------------- 
  
  
%% Define markers based on the raw data 
  
A=Peach2013102543; 
  
marker(1).label = 'shoulder'; 
marker(1).x = A(:,3); 
marker(1).y = A(:,4); 
marker(1).z = A(:,5); 
  
marker(2).label = 'elbow'; 
marker(2).x = A(:,6); 
marker(2).y = A(:,7); 
marker(2).z = A(:,8); 
  
marker(3).label = 'wrist'; 
marker(3).x = A(:,9); 
marker(3).y = A(:,10); 
marker(3).z = A(:,11); 
  
fs_marker = 100; % sampling rate 
t_marker = [0:length(marker(1).x)-1]/fs_marker; 
  
% Interpolate NaN points 
for i=1:3 
    marker(i).x = interp1(t_marker,marker(i).x,t_marker,'spline'); 
    marker(i).y = interp1(t_marker,marker(i).y,t_marker,'spline'); 
    marker(i).z = interp1(t_marker,marker(i).z,t_marker,'spline'); 
end 
  
%% Plot positions in 3D space 
  
% Define time of interest to plot 
t_interest = 1:(length(t_marker)-300);  
figure; 
plot3(marker(1).x(t_interest),marker(1).y(t_interest),marker(1).z(t_int
erest),'Color',[0.6,0.6,0.6]); hold on 
plot3(marker(2).x(t_interest),marker(2).y(t_interest),marker(2).z(t_int
erest),'Color',[0.6,0.6,0.6]); 
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plot3(marker(3).x(t_interest),marker(3).y(t_interest),marker(3).z(t_int
erest),'Color',[0.6,0.6,0.6]); 
  
% Define the time window of interest 
LowerBnd=1000;  
UpperBnd=4000; 
  
% 20: 1000-5500 
% 32: 2100-4000 
% 51: 1800-4800 
  
% Run vicon analyze code to obtain angle / force variables 
output = viconanalyze(sensor01,sensor02,sensor03,marker); 
signal = output.signal(LowerBnd:UpperBnd); 
resamp = output.ang(LowerBnd:UpperBnd); 
figure; plot(resamp,signal); 
  
 
function output = viconanalyze(sensor01,sensor02,sensor03,marker) 
  
% Calculate the joint angle from the law of cosines 
shoulder = [marker(1,1).x(:) marker(1,1).y(:) marker(1,1).z(:)]; 
elbow = [marker(1,2).x(:) marker(1,2).y(:) marker(1,2).z(:)]; 
wrist = [marker(1,3).x(:) marker(1,3).y(:) marker(1,3).z(:)]; 
shoulderelbow = distcalc3(shoulder,elbow); 
elbowwrist = distcalc3(elbow,wrist); 
wristshoulder = distcalc3(wrist,shoulder); 
ang = 180/pi*acos(-(wristshoulder.^2 - elbowwrist.^2 - 
shoulderelbow.^2)./(2*elbowwrist.*shoulderelbow)); 
  
% Upsample force sensor data 
sensor01 = interp(sensor01,2); 
sensor02 = interp(sensor02,2); 
sensor03 = interp(sensor03,2); 
  
% Convert sensor voltage to N 
sensor01=(0.1359*sensor01)-14.099; 
sensor02=(0.1072*sensor02)-10.935; 
  
% Resample the sensor data to adjust for timing issue of the Arduino 
start_time = find(sensor03>500,1); 
end_time = length(sensor03); 
anglewin = start_time:end_time; 
  
% Synchronize Vicon measurements with sensor data 
difference=sensor01(anglewin)-sensor02(anglewin); 
ind=1:(length(difference)); 
for i=2:(length(difference)) 
    ind(i)=ind(i-1)+1.0425; 
end 
difference2=resample(difference,10425,10000); 
  
% Filter the angle and force data 
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[b,a] = butter(5,8/100,'low'); 
signal=filtfilt(b,a,difference2); 
ang1=filtfilt(b,a,ang); 
  
% Assign output variables 
A=[length(ang),length(signal),length(ind)]; 
mini=min(A); 
output.ang=ang1(1:mini); 
output.signal=signal(1:mini); 
output.ind=ind(1:mini); 
  
% Plot the reformatted data 
figure; plot(output.ang/10-9,'b'); hold on; plot(output.signal,'r'); 
figure; plot(output.ang,'b'); hold on; plot(sensor01(anglewin),'m'); 
plot(sensor02(anglewin),'g'); 
  
end 
  
function dist = distcalc3(pt1,pt2) 
    dist = sqrt((pt1(:,1)-pt2(:,1)).^2+(pt1(:,2)-
pt2(:,2)).^2+(pt1(:,3)-pt2(:,3)).^2); 
end 
 
% --------------------------------------------------------- 
% 
% rigidityanalysis.m 
% 
% Created by: Kevin Mohsenian 
% Updated: 07-27-2014 
% 
% Description: Code that analyzes the force-angle variables 
%   and creates the appropriate plots. 
% 
% --------------------------------------------------------- 
  
%clear; clc; 
%load Trial3wVICON20_Peach_102613_analysis.mat; 
%load Trial11wVICON32_Peach_102613_analysis.mat; 
%load Trial17wVICON51_Peach_102613_analysis.mat; 
  
  
%% Define variables 
extct = 1; flxct = 1; k = 1; j = 1;  
threshold = 0; 
  
  
%% Define periods of joint articulation (e.g. extension-flexion) 
for i = 2:length(resamp)-1, 
    if resamp(i+1)-resamp(i) > threshold && resamp(i)-resamp(i-1) < 
threshold, 
        extct = 1; 
        ext(j).data(extct,1) = resamp(i); 
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        ext(j).data(extct,2) = signal(i); 
        extct = extct + 1; 
        ext_index(j) = i; 
        j = j + 1; 
    end 
    if resamp(i+1)-resamp(i) > threshold && resamp(i)-resamp(i-1) > 
threshold, 
        ext(j).data(extct,1) = resamp(i); 
        ext(j).data(extct,2) = signal(i); 
        extct = extct + 1; 
    end 
    if resamp(i+1)-resamp(i) < threshold && resamp(i)-resamp(i-1) > 
threshold, 
        flxct=1; 
        flx(k).data(flxct,1) = resamp(i); 
        flx(k).data(flxct,2) = signal(i); 
        flxct = flxct + 1; 
        flx_index(k) = i; 
        k = k + 1; 
    end 
    if resamp(i+1)-resamp(i) < threshold && resamp(i)-resamp(i-1) < 
threshold, 
        flx(k).data(flxct,1) = resamp(i); 
        flx(k).data(flxct,2) = signal(i); 
        flxct = flxct + 1; 
    end 
end 
  
  
  
%% Find the angle for which the flex and extend overlap 
  
% Interpolate the extension data and define the min/max extension 
angles 
min_extangle = 180; 
max_extangle = 0; 
for i=2:length(ext)-1, 
    TF=isempty(ext(i).data); 
    if TF==1 
        i=i+1; 
    elseif length(ext(i).data)<10 
        i=i+1; 
    end 
    extinterp(i).data(:,1) = 
ceil(min(ext(i).data(:,1))*10)/10:0.1:floor(max(ext(i).data(:,1))*10)/1
0; 
    extinterp(i).data(:,2) = 
interp1(ext(i).data(:,1),ext(i).data(:,2),extinterp(i).data(:,1)); 
    if min_extangle > min(extinterp(i).data(:,1)), 
        min_extangle = min(extinterp(i).data(:,1)); 
    end 
    if max_extangle < max(extinterp(i).data(:,1)), 
        max_extangle = max(extinterp(i).data(:,1)); 
    end 
end 
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% Interpolate the flexion data and define the min/max flexion angles 
min_flxangle = 180; 
max_flxangle = 0; 
for i=2:length(ext)-1, 
    flxinterp(i).data(:,1) = 
ceil(min(flx(i).data(:,1))*10)/10:0.1:floor(max(flx(i).data(:,1))*10)/1
0; 
    flxinterp(i).data(:,2) = 
interp1(flx(i).data(:,1),flx(i).data(:,2),flxinterp(i).data(:,1)); 
    if min_flxangle > min(flxinterp(i).data(:,1)), 
        min_flxangle = min(flxinterp(i).data(:,1)); 
    end 
    if max_flxangle < max(flxinterp(i).data(:,1)), 
        max_flxangle = max(flxinterp(i).data(:,1)); 
    end 
end 
  
% Define a matrix containing all of the full articulation cycles 
totalangle = 
length([min_extangle:0.1:max_extangle,fliplr(min_flxangle:0.1:max_flxan
gle)]); 
ang_matrix = ones(totalangle,min(length(extinterp)-2,length(flxinterp)-
2)); 
mov_matrix = NaN(totalangle,min(length(extinterp)-2,length(flxinterp)-
2)); 
for i=1:size(ang_matrix,2), 
    TF=isempty(extinterp(i+1).data); 
    if TF==1 
        i=i+1; 
    end 
    ang_matrix(:,i) = 
[min_extangle:0.1:max_extangle,fliplr(min_flxangle:0.1:max_flxangle)]'; 
    ind = find(abs(ang_matrix(:,i)-extinterp(i+1).data(1,1))<10^-6,1); 
    mov_matrix(ind:length(extinterp(i+1).data(:,1))+ind-1,i) = 
extinterp(i+1).data(:,2); 
    ind = find(abs(ang_matrix(:,i)-flxinterp(i+1).data(end,1))<10^-
6,1,'last'); 
    mov_matrix(ind:length(flxinterp(i+1).data(:,1))+ind-1,i) = 
flipud(flxinterp(i+1).data(:,2)); 
end 
  
  
%% Cluster analysis 
  
% Define variables 
numtypes = 5; 
  
% Perform the PCA 
[coeff,score] = pca(mov_matrix'); 
T = clusterdata(score,numtypes); 
  
% Sort the cluster matrix into groups 
for i = 1:numtypes, 
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    clustergrp(i).ind = find(T==i); 
end 
  
% Select the cluster with the largest number of indices 
clustertype = 1; 
for i = 1:numtypes, 
    maxind = length(clustergrp(i).ind); 
    if maxind > clustertype, 
        clustertype = i; 
    end 
end 
for i = 1:length(clustergrp(clustertype).ind), 
    ext_new(i).data = extinterp(clustergrp(clustertype).ind(i)+1).data; 
    flx_new(i).data = flxinterp(clustergrp(clustertype).ind(i)+1).data; 
    ang_matrix_new(:,i) = ang_matrix(:,clustergrp(clustertype).ind(i)); 
    mov_matrix_new(:,i) = mov_matrix(:,clustergrp(clustertype).ind(i)); 
end 
  
% Calculate the average force-angle waveform 
ang_matrix_avg = mean(ang_matrix_new,2); 
mov_matrix_avg = zeros(size(mov_matrix_new,1),1); 
ctr = 1; 
for i=1:size(mov_matrix_new,1), 
    for j=1:size(mov_matrix_new,2), 
        if ~isnan(mov_matrix_new(i,j)) 
            mov_matrix_avg(i) = mov_matrix_avg(i)+mov_matrix_new(i,j); 
            ctr = ctr + 1; 
        end 
    end 
    if mov_matrix_avg(i) == 0, 
        mov_matrix_avg(i) = NaN; 
    end 
    mov_matrix_avg(i) = mov_matrix_avg(i)/ctr; 
    ctr = 1; 
end 
     
% Plot the primary cluster group 
for i = 1:numtypes,  
    figure; 
    for j = 1:length(clustergrp(i).ind), 
        
plot(extinterp(clustergrp(i).ind(j)+1).data(:,1),extinterp(clustergrp(i
).ind(j)+1).data(:,2),'go'); hold on;  
        
plot(flxinterp(clustergrp(i).ind(j)+1).data(:,1),flxinterp(clustergrp(i
).ind(j)+1).data(:,2),'bo') 
    end 
    plot(ang_matrix_avg,mov_matrix_avg,'k-','LineWidth',4); 
    xlabel('Angle (degrees)','FontSize',20) 
    ylabel('Force (N)', 'FontSize',20) 
end 
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%% Perform the angle-force area calculation 
  
anglecrop = 5/0.1;  % cropping both sides by 5 degrees (sampling rate 
0.1 Hz) 
for i=1:min(length(ext_new),length(flx_new)), 
    ext_new(i).bounds = 1+anglecrop:length(ext_new(i).data(:,1))-
anglecrop; 
    flx_new(i).bounds = 1+anglecrop:length(flx_new(i).data(:,1))-
anglecrop; 
    area(i) = (sum(ext_new(i).data(ext_new(i).bounds,2))-
sum(flx_new(i).data(flx_new(i).bounds,2)))*0.1; 
    area_norm(i) = 
area(i)/mean([length(ext_new(i).bounds),length(ext_new(i).bounds)]); 
    if area_norm(i)==Inf 
        area_norm(i)=NaN; 
    end 
    if area_norm(i)==-Inf 
        area_norm(i)=NaN; 
    end 
end 
area_mean = mean(area); 
area_stdev = std(area); 
area_norm_mean = nanmean(area_norm); 
area_norm_stdev = nanstd(area_norm); 
area_export=[area_mean;area_stdev;area_norm_mean;area_norm_stdev]; 
 
 
